Treatment Failure in Pediatric Tinea Capitis
Immediate Assessment and Second-Line Therapy
- The British Association of Dermatologists recommends switching to itraconazole as second-line therapy at 5 mg/kg/day for 2-4 weeks, while reassessing for compliance issues, inadequate drug absorption, and potential reinfection sources, in cases of treatment failure with griseofulvin 1, 2
- Compliance verification is essential, as absorption of griseofulvin is significantly enhanced by fat intake, and the child should be taking the medication consistently with fatty food 3, 4
- The dose of griseofulvin should be 15-20 mg/kg/day (or up to 25 mg/kg/day for resistant cases), and anything less may be considered subtherapeutic 1, 2
Critical Interpretation of Negative Culture and Alternative Therapies
- The British Association of Dermatologists guidelines acknowledge starting empiric treatment when clinical signs (scale, lymphadenopathy, alopecia) are present despite negative microscopy, as false negatives are common in tinea capitis due to sampling technique issues 3
- Itraconazole demonstrates efficacy against both Trichophyton and Microsporum species, making it ideal when the organism is unknown, with a dosing regimen of 5 mg/kg/day for 2-4 weeks (or 50-100 mg/day for 4 weeks) 1, 2
- Terbinafine may be considered as an alternative, with dosing by weight: <20 kg: 62.5 mg/day; 20-40 kg: 125 mg/day; >40 kg: 250 mg/day for 2-4 weeks, but it is highly effective for Trichophyton and relatively ineffective for Microsporum species 1, 2
Monitoring and Endpoint
- Repeat mycology sampling is necessary before switching therapy to guide treatment choice, and treatment endpoint is mycological cure, not just clinical improvement, with continued sampling every 2-4 weeks until cultures are negative 2, 3, 4
- If clinical improvement but positive cultures persist, continue current therapy for an additional 2-4 weeks 1, 2